Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital

Abstract EN

Extended-spectrum β lactamases (ESBLs) continue to be a major challenge in clinical setups world over, conferring resistance to the expanded-spectrum cephalosporins.

An attempt was made to study the prevalence of ESBL-producing Klebsiella pneumoniae clinical isolates in a tertiary care hospital in Kurnool.

A total of hundred collected isolates of Klebsiella pneumoniae was studied for their susceptibility patterns to various antibiotics and detection of ESBL producers by double disc synergy test (DDST) and phenotypic confirmatory disc diffusion test (PCDDT).

Of the 100 isolates tested for their antibiogram, 61% isolates have shown susceptibility to 3rd-generation cepholosporins and 39% were resistant.

Amoxycillin showed the highest percentage of resistance followed by tetracyclins and cotrimoxazole.

Among 39 resistant isolates of Klebsiella pneumoniae, 17 were ESBL producers detected by DDST and PCDDT.

ESBL producers were more in the hospital isolates (28%) compared to community isolates (6%).

Maximum percentage of ESBL producers were noticed from blood sample with 57.14%.

In the present study, a large number of isolates were found to be multidrug resistant and ESBL producers.

PCDDT was found to be better than DDST in the detection of ESBLs.

Continued monitoring of drug resistance is necessary in clinical settings for proper disease management.